Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
crispr
4
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
4
×
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
4
×
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
4
×
startups
4
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
boston top stories
cancer immunotherapy
clinical trials
deals
eli lilly
fda
ipo
novartis
allergan
alzheimer's disease
What
bio
roundup
companies
life
new
science
acquisitions
announced
approval
bails
biogen’s
biopharmaceutical
black
brand
bridgebio
capital
car
ceo
collabs
continue
convo
covid
daniel
deal
debut
develop
diamond
diamond’s
drug
drugs
earlier
emerges
failures
firm
gilead
gilead’s
grab
headlines
help
ichnos
Language
unset
Current search:
crispr
×
biotech
×
" national top stories "
×
" seattle top stories "
×
" san diego top stories "
×
startups
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More